China’s State FDA Loses Independence in Merger With Ministry Of Health
This article was originally published in PharmAsia News
Executive Summary
BEIJING - In a major revamping of China's drug regulatory system, China's State FDA will lose part of its rule-making authority during an ongoing merger with the Ministry of Health
You may also be interested in...
2008 In Review: China’s Major Legal And Regulatory Changes For Health-Care Sector
SFDA merger into Ministry of Health and passage of Anti-Monopoly Law among major events whose impacts will be felt in years to come.
2008 In Review: China’s Major Legal And Regulatory Changes For Health-Care Sector
SFDA merger into Ministry of Health and passage of Anti-Monopoly Law among major events whose impacts will be felt in years to come.
2008 In Review: China’s Major Legal & Regulatory Changes For Healthcare Sector
BEIJING - In a review of the major legal and regulatory measures that changed China's healthcare landscape in 2008, Chinese and European lawyers stated the merger of the State FDA into the Ministry of Health is likely to have the most significant impact into the future